As a former Oncology Drug Access Navigator (DAN), I understood that my patients needed treatment urgently for their cancer, and they didn’t have time to wait for it […]
In the fourth of our six-part series on comparing the PA process in Canada vs. the U.S. we address the importance of regular prior authorization program review.
In this third in our six-part series on prior authorization (PA) in Canada vs the U.S. we address the selective application of PA.
Since 2020, the conversation around improving the prior authorization process and experience has been gaining traction in Canada. Learn what Canadian stakeholders can take away from American developments.
Are you a physician, pharmacist, or other prescriber that has patients with a prescription for specialty medications? If you are, it’s likely that your patients have a prescription for a therapy or medication that requires prior authorization, and they probably have questions about it.
Do you represent a patient support/assistance program (PSP/PAP)? If you do, it’s likely that the patients you help have a prescription for a therapy or medication that requires prior authorization, and they probably have questions about it.
The Simplify Prior Authorization initiative is an advocate for education about prior authorization (PA) and improvement in current prior authorization practices and processes. If your organization is interested in finding out more, getting involved, or in sponsorship of this important initiative, please contact us via the link below.